Abstract

Mean Contralateral Salivary Gland Dose (Parotid and Submandibular) Accurately Predicts for Patient-Reported Xerostomia After Deintensified Chemoradiation Therapy for Human Papillomavirus–Associated Oropharynx Cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call